PATENT AND TECHNOLOGY DEVELOPMENT AND LICENSE AGREEMENTAgreement • April 15th, 2016 • Moleculin Biotech, Inc. • Pharmaceutical preparations • Texas
This AGREEMENT (“AGREEMENT”) is made on this 28th day of June, 2012, by and between ANNAMED, INC, a Texas corporation (“ANNAMED”), and DERMIN Sp. zo.o.a limited liability company having a principal place of business located at PL-00-116 Warzawa, ul, Świętkorzyska 36/17, Poland (“LICENSEE”).
ContractTechnology Rights and Development License Agreement • April 15th, 2016 • Moleculin Biotech, Inc. • Pharmaceutical preparations • Texas
This TECHNOLOGY RIGHTS AND DEVELOPMENT LICENSE Agreement (the “Agreement”) dated as of [month] [date], [year] (the “Effective Date”) is entered into by and between Moleculin Biotech, Inc. (“MBI”), a Delaware corporation, having a business address of 1973 W. Clay St. Houston, TX 77019 and Houston Pharmaceuticals, Inc., (“HPI”), a Texas Corporation, having a business address of 4239 Emory St., Houston, TX 77005. MBI and HPI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ESCROW DEPOSIT AGREEMENTEscrow Deposit Agreement • April 15th, 2016 • Moleculin Biotech, Inc. • Pharmaceutical preparations • New York
This ESCROW DEPOSIT AGREEMENT (this “Agreement”) dated as of this 1st day of March 2016, by and among MOLECULIN BIOTECH, INC., a Delaware corporation (the “Company”), having an address at 2575 West Bellfort, Suite 333, Houston, Texas 77054, BONWICK CAPITAL PARTNERS, LLC, a New York limited liability company (the “Underwriter”), having an address at 40 West 57th Street, 28th Floor, New York, New York 10019, and SIGNATURE BANK (the “Escrow Agent”), a New York State chartered bank, having an office at 950 Third Avenue, 9th Floor, New York, NY 10022. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Amendment No. 1 to Form S-1 Registration Statement (the “Registration Statement”), dated February 16, 2016.
